DGFT made export of Active Pharmaceutical Ingredients and formulations made from APIs free

Apr 07, 2020 | by Avantis RegTech Legal Research Team


Finance & Taxation Compliance

The Directorate General of Foreign Trade (DGFT) on April 06, 2020, has made export of Active Pharmaceutical Ingredients and formulations made from APIs free with immediate effect.

DGFT amends the Notification No. 50/2015-2020 dated March 03, 2020, regarding export of APIs and formulations made from these APIs is restricted. The descriptions of APIs and formulation made from APIs are as under:

Tinidazole; Metronidazole; Acyclovir; Vitamin B1; Vitamin B6; Vitamin B12; Progesterone; Chloramphenicol; Erythromycin Salts; Neomycin; Clindamycin Salts; Ornidazole; Formulations made of Chloramphenicol; Formulations made of Erythromycin Salts; Formulations made of Clindamycin Salts; Formulations made of Progesterone; Formulations made of Vitamin B1; Formulations made of Vitamin B12; Formulations made of Vitamin B6; Formulations made of Neomycin; Formulations made of Ornidazole; Formulations made of Metronidazole; Formulations made of Tinidazole; Formulations made of Acyclovir.

Therefore, the above Active Pharmaceutical Ingredients and formulations made from APIs are free for export with immediate effect.

[Notification No. 02/2015-2020]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.